Trial Profile
A Phase I, 2-panel, Open-label, Randomized, Crossover Trial in Healthy Subjects to Investigate the Pharmacokinetic Interaction Between TMC435 and Transporter Substrates, Digoxin and Rosuvastatin.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Dec 2012
Price :
$35
*
At a glance
- Drugs Digoxin (Primary) ; Rosuvastatin (Primary) ; Simeprevir (Primary)
- Indications Arrhythmias; Heart failure; Hepatitis C; Hypercholesterolaemia
- Focus Pharmacokinetics
- Sponsors Janssen R&D Ireland
- 23 Dec 2011 Actual initiation date changed from Feb 2011 to Jan 2011 as reported by ClinicalTrials.gov.
- 14 Jul 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Apr 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.